Income Statement - Tango Therapeutics, Inc. (TNGX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total revenue | 62.38 | 42.07 | 36.53 | 24.86 | 37.04 | 7.66 | 24.65 |
| Cost of revenue | 2.28 | 2.50 | 115.20 | 4.03 | 1.97 | 1.63 | 32.27 |
| Gross profit | 60.10 | 42.07 | 36.53 | 24.86 | 37.04 | 6.03 | -7.63 |
| Total operating expenses | 171.39 | 187.66 | 150.70 | 135.93 | 95.23 | 58.23 | 7.54 |
| Operating income | -111.29 | -145.60 | -114.17 | -111.07 | -58.19 | -52.20 | -15.16 |
| Non-operating income (net) | 9.70 | 15.50 | 12.56 | 2.95 | 0.25 | 0.23 | 1.07 |
| Income before tax | -101.59 | -130.09 | -101.61 | -108.12 | -57.94 | -51.97 | -14.10 |
| Income tax expense | 0.00 | 0.21 | 0.13 | 0.05 | 0.29 | -0.11 | |
| Net income | -101.59 | -130.30 | -101.74 | -108.18 | -58.24 | -51.97 | -14.10 |
Show Quarterly Income Statement
Income Statement - Tango Therapeutics, Inc. (TNGX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Sep-20 | Jun-20 | Mar-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 53.81 | 3.18 | 5.39 | 4.12 | 11.61 | 19.88 | 6.47 | 5.43 | 10.73 | 14.60 | 5.77 | 6.41 | 6.92 | 5.77 | 5.76 | 5.72 | 6.79 | 18.15 | 6.39 | 9.14 | -11.26 | 5.06 | 4.71 |
| Cost of revenue | 0.46 | 0.48 | 0.56 | 0.63 | 0.62 | 0.63 | 0.63 | 0.62 | 0.61 | 1.51 | 1.46 | 1.45 | 1.22 | 0.69 | 0.67 | 0.58 | 21.92 | 0.46 | 0.45 | 0.43 | 12.98 | 11.13 | 10.82 | ||
| Gross profit | -0.46 | -0.48 | 53.81 | 2.56 | 5.39 | 4.12 | 11.61 | 19.88 | 6.47 | 5.43 | 10.12 | 13.09 | 4.31 | 4.96 | 5.70 | 5.09 | 5.09 | 5.14 | -15.14 | 17.69 | 5.94 | 8.71 | -24.24 | -6.07 | -6.11 |
| Total operating expenses | 48.31 | 41.39 | 39.74 | 43.52 | 47.92 | 45.03 | 44.49 | 49.43 | 48.73 | 40.44 | 35.75 | 36.34 | 34.59 | 35.53 | 35.62 | 30.29 | 30.47 | 27.12 | 4.43 | 22.25 | 18.02 | 17.65 | 2.52 | 2.38 | 1.95 |
| Operating income | -48.77 | -41.86 | 14.07 | -40.97 | -42.53 | -40.91 | -32.88 | -29.55 | -42.26 | -35.01 | -25.63 | -23.25 | -30.29 | -30.57 | -29.92 | -25.20 | -25.38 | -21.98 | -19.57 | -4.56 | -12.08 | -8.94 | -26.76 | -8.44 | -8.06 |
| Non-operating income (net) | 3.26 | 3.06 | 1.80 | 2.15 | 2.69 | 3.29 | 3.77 | 4.07 | 4.38 | 4.30 | 3.39 | 2.60 | 2.28 | 1.56 | 0.87 | 0.35 | 0.17 | 0.12 | 0.04 | 0.04 | 0.05 | 0.07 | -0.05 | 0.05 | 0.15 |
| Income before tax | -45.51 | -38.80 | 15.87 | -38.82 | -39.84 | -37.62 | -29.11 | -25.49 | -37.87 | -30.72 | -22.24 | -20.65 | -28.01 | -29.01 | -29.05 | -24.86 | -25.21 | -21.87 | -19.53 | -4.51 | -12.03 | -8.86 | -26.80 | -8.39 | -7.91 |
| Income tax expense | 0.00 | -0.06 | -0.01 | 0.04 | 0.03 | 0.05 | 0.05 | 0.07 | 0.04 | 0.05 | 0.02 | 0.06 | -2.28 | 0.05 | -0.87 | 0.00 | -0.17 | 0.18 | 0.06 | -0.02 | 0.07 | 0.00 | 0.05 | ||
| Net income | -45.51 | -38.75 | 15.88 | -38.85 | -39.88 | -37.67 | -29.17 | -25.55 | -37.91 | -30.76 | -22.26 | -20.71 | -28.01 | -29.06 | -29.05 | -24.86 | -25.21 | -22.05 | -19.59 | -4.49 | -12.11 | -8.86 | -26.80 | -8.39 | -7.91 |